These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17881329)

  • 1. Efficacy and safety of insulin detemir.
    Raskin P
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():21-32. PubMed ID: 17881329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin detemir and basal insulin therapy.
    Russell-Jones DL
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():7-13. PubMed ID: 17881327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of insulin detemir.
    Kurtzhals P
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():14-20. PubMed ID: 17881328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.
    Chapman TM; Perry CM
    BioDrugs; 2005; 19(1):67-9. PubMed ID: 15691219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive diabetes therapy and body weight: focus on insulin detemir.
    Bush MA
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():33-44. PubMed ID: 17881330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Perry CM
    Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
    Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
    Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin detemir: a long-acting insulin product.
    Jones MC; Patel M
    Am J Health Syst Pharm; 2006 Dec; 63(24):2466-72. PubMed ID: 17158694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update).
    Philis-Tsimikas A
    Expert Opin Pharmacother; 2008 Aug; 9(12):2181-95. PubMed ID: 18671472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin detemir in the treatment of type 1 and type 2 diabetes.
    Philips JC; Scheen A
    Vasc Health Risk Manag; 2006; 2(3):277-83. PubMed ID: 17326333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levemir Early Clinical Experience Case Series.
    Mayerson AB
    Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():45-52. PubMed ID: 17881331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
    Lüddeke HJ; Sreenan S; Aczel S; Maxeiner S; Yenigun M; Kozlovski P; Gydesen H; Dornhorst A;
    Diabetes Obes Metab; 2007 May; 9(3):428-34. PubMed ID: 17391171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic patients from the Belgian PREDICTIVE Cohort.
    Preumont V; Buysschaert M; De Beukelaer S; Mathieu C
    Acta Clin Belg; 2009; 64(1):49-55. PubMed ID: 19317241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
    Marre M; Pinget M; Gin H; Thivolet C; Hanaire H; Robert JJ; Fontaine P
    Diabetes Metab; 2009 Dec; 35(6):469-75. PubMed ID: 19914118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects.
    Perriello G; Caputo S; De Pergola G; Di Carlo A; Grassi G; Lapolla A; Pata P; Solerte SB; Zaccardi F
    Expert Opin Pharmacother; 2011 Nov; 12(16):2449-55. PubMed ID: 21988213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin detemir--a new basal insulin analog.
    Goldman-Levine JD; Lee KW
    Ann Pharmacother; 2005 Mar; 39(3):502-7. PubMed ID: 15657117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE.
    Fontaine P; Gin H; Pinget M; Thivolet C; Hanaire H; Robert JJ; Marre M; Venkatanarasimhachar S
    Adv Ther; 2009 May; 26(5):535-51. PubMed ID: 19513632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin detemir: from concept to clinical experience.
    Home P; Kurtzhals P
    Expert Opin Pharmacother; 2006 Feb; 7(3):325-43. PubMed ID: 16448327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.